Skip to content

Clinical trials

Observational Immunologic Deficiency Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunologic Deficiency Syndromes Phase: Observational Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20061
20095
20104
20113
20132
20143
20155
20164
20176
20183
20192
20209
20217
20232
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting24
Unknown status9
Terminated6
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)16
National Cancer Institute (NCI)6
University of California, San Francisco4
University Hospital, Strasbourg, France3
Children's Hospital of Fudan University2
University of Colorado, Denver2
ANRS, Emerging Infectious Diseases1
Advanced Neurosciences Institute1
Assistance Publique - Hôpitaux de Paris1
Bina Nusantara University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunologic Deficiency Syndromes75
Primary Immunodeficiency Diseases8
Autoimmune Diseases7
Infections6
Anemia, Sickle Cell4
Fanconi Anemia4
HIV Infections4
Hematologic Neoplasms4
Hemoglobinopathies4
Lymphoma4

Trials

Showing 76 to 75 of 75. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.